Comparison of Thrombocyte Indices and Immature Platelet between Preeclampsia and Normal Pregnancy

Authors

  • Chakrawati Hayuningsih Installation of Clinical Laboratory Tangerang District General Hospital, Tangerang
  • Leni Lismayanti Department of Clinical Pathology, Faculty of Medicine, Padjadjaran University/Dr. Hasan Hasan Sadikin Hospital, Bandung
  • Anna Tjandrawati Department of Clinical Pathology, Faculty of Medicine, Padjadjaran University/Dr. Hasan Hasan Sadikin Hospital, Bandung

DOI:

https://doi.org/10.24293/ijcpml.v30i1.2075

Keywords:

Platelet indices, IPF, preeclampsia, normal pregnancy

Abstract

The primary pathophysiology of preeclampsia is abnormal trophoblast invasion, vasospasm, and endothelial dysfunction occurring, as well as platelet activation, increased platelet consumption, and the stimulation of the release of new platelets, which affects the platelet indices and immature platelets. This study compared the platelet indices (Mean Platelet Volume=MPV, Platelets Distribution Width=PDW, Platelet Large Cell Ratio=PLCR, and Immature Platelet Fraction (IPF) between preeclampsia and normal pregnancy. This research was an unpaired comparative analytic observational study with a cross-sectional design conducted in the Tangerang District General Hospital from February to August 2020. The platelet indices (MPV, PDW, PLCR) and IPF of preeclampsia subjects (n=33) at Tangerang District General Hospital and normal pregnant subjects (n=38) at Annisa Hospital Tangerang were examined using the Sysmex XN-1000 automatic hematology analyzer. Comparative platelet indices and IPF analysis were carried out by independent T-test or Man-Whitney test. Receiver Operating Characteristics (ROC) analysis was performed to obtain the cut-off value of the platelet indices and IPF to differentiate preeclampsia and normal pregnancy. The platelet indices and IPF were significantly higher in preeclampsia. The mean (SD) MPV was 10.86 (0.9) fL and 10. (0.89) fL, p<0.001; PDW 12.7 (8.7-19.1) fL and 10.85 (8.5-15.7) fL, p<0.001; PLCR 31.96 (7.02) % and 25.06 (6.92) %, p<0.001; and IPF 8.50 (3.10-20.40)% and 2.75 (1.2-9.4)%, p<0.001, respectively in preeclampsia and normal pregnancy. ROC analysis showed that an IPF with an AUC of 0.88 (95% confidence interval (CI) 0.78-0.95) with an IPF cut-off value of >6.5% was a good marker, while the MPV cut-off >10.2 fL, AUC 0.75(95% CI 0.63-0.84), PDW cut-off >11.3fL, AUC 0.77 (95%CI 0.65-0.86) and PLCR cut-off >26.1%, AUC 0.76 (95% CI 0.65-0.85) were good enough markers to differentiate preeclampsia from normal pregnancy. Platelet indices and IPF were statistically significantly higher in preeclampsia. The IPF parameter is a good marker, while the platelet indices can be a pretty good marker to distinguish preeclampsia and normal pregnancy. The IPF parameter and platelet indices can be proposed as a routine examination in pregnancy. Changes in IPF and platelet indices can be early signs of preeclampsia or the development of preeclampsia.  

Downloads

Download data is not yet available.

References

Nooh AM, Abdeldayem HM. Changes in Platelet during Pregnancy as Potential Markers for Prediction of Preeclampsia Development. Journal of Obstetrics and Gynecology, 2015; 5: 703-12.

Thalor N, Singh K, Pujani M, Chauhan V, Agarwal C, Ahuja R. A correlation between platelet indices and preeclampsia. Hematol Transfus Cell Ther, 2019; 41(2): 129-33.

Manchanda J, Malik A. Study of platelet indices in pregnancy-induced hypertension. Medical Journal Armed Forces India, 2020; 76: 161-165.

Jeske WP. Platelet production, structure, and function. In: Keohan EM, Smith LJ, Walenga JM, Rodaks’s hematology clinical principles and applications. 5 Ed., Philadelphia, Elsivier Inc, 2016; 136-53.

Bain BJ, Briggs C. Basic hematological techniques. In: Bain Bj, Bates I, Laffa MA ed. Dacie and Lewis, Practical Haematology. 12 Ed., Philadelphia, Elsevier Inc, 2017; 40-42.

Tesfay F, Negash M, Alemu J, Yahya M, Teklu G, et al. Role of parameters in early detection and prediction of severity of preeclampsia: A comparative cross-sectional study at Ayder Comprehensive Specialized and Mekelle General Hospitals, Mekelle, Tigray, Ethiopia. PLos One, 2019; 1-10.

Donthi D, Kumar U, Gopi A. Platelet indices in preeclampsia and eclampsia. National Journal of Laboratory Medicine, 2018; 7(2): 1-4.

Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rause DJ, Spong CY. Hipertensi dalam kehamilan. In: Cuningham GF et al. Setia R editor, Obstetri Williams. Volume 2, Ed 23., Jakarta, Penerbit Buku Kedokteran, ECG, 2019; 740-52.

Pedoman Nasional Pelayanan Kedokteran. Diagnosis dan tatalaksana pre- eklamsia. Perkumpulan Obstetri dan Ginekologi Indonesia. Himpunan Kedokteran Feto Maternal, 2016; 6-9

Tanner MS, Davey MA, Mol BW, Rolnik DL. The Evolution of the diagnostic criteria of preeclampsia-eclampsia. American Journal of Obstetrics & Gynecology, 2022; S835-S843.

Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. The Japanese Society of Hypertension. Hypertension Research, 2017; 40: 213-220.

Amita K, Nithin KH, Shobha SN, Vijay S. The role of platelet parameters as a biomarker in the diagnosis and in predicting the severity of preeclampsia. Indian Journal of Pathology and Oncology, 2015; 2(2): 57-60.

Reddy SG, Prasad CSBR. Significance of platelet indices as severity marker in nonthrombocytopenic preeclampsia cases. Journal Laboratory Physicians, 2019; 11: 186-91.

Moreas D, Munhoz TP, da Costa BEP, Hentschke MR, Sontag F, et al. Immature platelet fraction in hypertension pregnancy. Platelets, 2015; 1-5.

Bernstein U, Kaiser T, Stepan H, Jank A. The immature platelet fraction in hypertensive disease during pregnancy. Archives of Gynecology and Obstetrics, Available from: https://dol.org/10.1007/s00404-019-05102-2 (accessed February 5, 2019).

Gupta A, Hak J, Sunil I, Gupta A. Platelet count estimation: A prognostic index in pregnancy-induced hypertension. Int J of Reprod, Contracept, Obstet and Gynecol, 2018; 7(2): 476-82.

Singh A, Varma R. Role of Platelet Distribution Width (PDW) and platelecrit in the assessment of nonthrombocytopenic preeclampsia and eclampsia. The Journal of Obstetrics and Gynecology of India, 2018; 68(4): 289-293.

Meintker L, Krause SW. Reticulated platelets-clinical application and future perspectives. J Lab Med, 2020; 44(5): 241-253.

Alsheeha MA, Alaboudi RS, Alghasham M, Iqbal J, Adam I. Platelet count and platelet indices in women with preeclampsia. Vasc Health Risk Manag, 2016; 12: 477-80.

Umezuluike BS, Anikwe CC, Nnachi OC, Iwe BCA, Ifemelumma CC, Dimejesi IBO. Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study. Heliyon, 2021; e08484: 1-8.

Buch AC, Patil AA, Agrawal NS, Karia KM, Kaur M, Patro N. Evaluation of platelet count and platelet indices and their significance in preeclampsia. Sch.J.App. Med. Sci, 2018; 6(4): 1598-1602.

Downloads

Submitted

2022-12-21

Accepted

2023-04-05

Published

2023-11-03

How to Cite

[1]
Hayuningsih, C., Lismayanti, L. and Tjandrawati, A. 2023. Comparison of Thrombocyte Indices and Immature Platelet between Preeclampsia and Normal Pregnancy. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 30, 1 (Nov. 2023), 54–59. DOI:https://doi.org/10.24293/ijcpml.v30i1.2075.

Issue

Section

Articles